Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005413
Filing Date
2025-04-24
Accepted
2025-04-24 16:15:40
Documents
17
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A elev-20250605xdef14a.htm   iXBRL DEF 14A 646880
2 GRAPHIC elev-20250605xdef14a_a001.jpg GRAPHIC 5269
3 GRAPHIC elev-20250605xdef14a_bg001.jpg GRAPHIC 118577
4 GRAPHIC elev-20250605xdef14a_bg002.jpg GRAPHIC 92455
  Complete submission text file 0001558370-25-005413.txt   1434719

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20250605.xsd EX-101.SCH 3682
6 EX-101.LAB elev-20250605_lab.xml EX-101.LAB 3685
7 EX-101.PRE elev-20250605_pre.xml EX-101.PRE 3531
19 EXTRACTED XBRL INSTANCE DOCUMENT elev-20250605xdef14a_htm.xml XML 4564
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40523 | Film No.: 25867533
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)